v3.26.3
Notes Receivable
9 Months Ended
Sep. 30, 2026
Receivables [Abstract]  
Notes Receivable

Note 4. Notes Receivable

 

On February 19, 2021, Impact BioMedical, Inc, entered into a promissory note with an individual. The Company loaned the principal sum of $206,000, with interest at a rate of 6.5%, and maturity date of August 19, 2022. The interest rate and maturity were both later amended to be 5% and February 19, 2029, respectively. Monthly payments are due on the twenty-first day of each month and continuing each month thereafter until February 19, 2029. This note is secured by certain real property situated in Collier County, Florida. The outstanding principal and interest as of September 30, 2026, and December 31, 2025 was approximately $199,000 and $198,000, respectively. As of September 30, 2026, approximately $14,000 is classified in Current notes receivable and the remaining $185,000 is classified as Notes receivable on the accompanying balance sheet. As of December 31, 2025, $198,000 is classified in Current notes receivable on the accompanying consolidated balance sheet.